Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines | Zendy

Sebastian Szmit | Zendy; Przemysław Langiewicz | Zendy; Jakub Żłnierek | Zendy; Paweł Nurzyński | Zendy; Magdalena Zaborowska-Szmit | Zendy; Krzysztof J. Filipiak‬ | Zendy; Grzegorz Opolski | Zendy; Cezary Szczylik | Zendy

Open Access

Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines

Author(s) -

Sebastian Szmit,

Przemysław Langiewicz,

Jakub Żłnierek,

Paweł Nurzyński,

Magdalena Zaborowska-Szmit,

Krzysztof J. Filipiak‬,

Grzegorz Opolski,

Cezary Szczylik

Publication year - 2011

Publication title -

kidney and blood pressure research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 51

eISSN - 1423-0143

pISSN - 1420-4096

DOI - 10.1159/000329933

Subject(s) - sunitinib , renal cell carcinoma , medicine , oncology , cancer research

This retrospective analysis compared progression-free survival (PFS) in 111 patients who developed or had preexisting hypertension with those who did not during treatment with second-line sunitinib. Secondary objectives included overall survival (OS) and safety.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research